JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184678

Anti-CX3CR1 antibody [8E10.D9]

1

(1 Review)

|

(7 Publications)

Mouse Monoclonal CX3CR1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human CX3CR1 aa 200-250 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

CMKBRL1, GPR13, CX3CR1, CX3C chemokine receptor 1, C-X3-C CKR-1, Beta chemokine receptor-like 1, Fractalkine receptor, G-protein coupled receptor 13, V28, CMK-BRL-1, CMK-BRL1

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CX3CR1 antibody [8E10.D9] (AB184678)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CX3CR1 antibody [8E10.D9] (AB184678)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human brain tissue labeling CX3CR1 with ab184678 at 1/50 dilution.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

8E10.D9

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human CX3CR1 aa 200-250 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P49238

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol." }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Cow": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rabbit": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CX3CR1 also known as fractalkine receptor is a seven-transmembrane G protein-coupled receptor. It has a molecular weight of about 40 kDa. This receptor is expressed in various tissues particularly on immune cells like monocytes natural killer cells T cells and microglia. CX3CR1 binds to its ligand CX3CL1 or fractalkine which is a chemokine involved in directing cell movement. The receptor-ligand interaction is critical for the adhesion and migration of leukocytes to inflammatory sites.
Biological function summary

CX3CR1 plays a significant role in immune regulation and cellular migration. It is not part of a larger protein complex but interacts directly with monocyte and microglia cells influencing their activity. CX3CR1 is recognized as a marker for microglia in flow cytometry applications assisting in the identification of these brain-resident immune cells. The receptor is frequently studied using monoclonal antibodies like anti-CX3CR1 and is subject to inhibition by CX3CR1 antagonists such as 8e10 affecting its function in immune responses.

Pathways

CX3CR1 involves itself heavily in the chemokine signaling pathway and the inflammatory response pathway. Its interaction with CX3CL1 influences the PI3K-Akt signaling pathway modulating cell survival and proliferation. The receptor works in conjunction with CCR2 in monocyte navigation impacting the inflammatory cascade during immune response. Their coordinated action is important for cellular trafficking to sites requiring immune intervention.

CX3CR1 has associations with neurodegenerative diseases such as Alzheimer's disease as well as with atherosclerosis. Changes in its expression and function can exacerbate these conditions. In Alzheimer's disease microglial CX3CR1 may mediate neuroinflammatory processes affecting plaque buildup. In atherosclerosis the receptor is involved in monocyte recruitment to plaques influenced by the related protein fractalkine. Understanding these relationships provides insights into potential therapeutic targets for modulating disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for the C-X3-C chemokine fractalkine (CX3CL1) present on many early leukocyte cells; CX3CR1-CX3CL1 signaling exerts distinct functions in different tissue compartments, such as immune response, inflammation, cell adhesion and chemotaxis (PubMed : 12055230, PubMed : 23125415, PubMed : 9390561, PubMed : 9782118). CX3CR1-CX3CL1 signaling mediates cell migratory functions (By similarity). Responsible for the recruitment of natural killer (NK) cells to inflamed tissues (By similarity). Acts as a regulator of inflammation process leading to atherogenesis by mediating macrophage and monocyte recruitment to inflamed atherosclerotic plaques, promoting cell survival (By similarity). Involved in airway inflammation by promoting interleukin 2-producing T helper (Th2) cell survival in inflamed lung (By similarity). Involved in the migration of circulating monocytes to non-inflamed tissues, where they differentiate into macrophages and dendritic cells (By similarity). Acts as a negative regulator of angiogenesis, probably by promoting macrophage chemotaxis (PubMed : 14581400, PubMed : 18971423). Plays a key role in brain microglia by regulating inflammatory response in the central nervous system (CNS) and regulating synapse maturation (By similarity). Required to restrain the microglial inflammatory response in the CNS and the resulting parenchymal damage in response to pathological stimuli (By similarity). Involved in brain development by participating in synaptic pruning, a natural process during which brain microglia eliminates extra synapses during postnatal development (By similarity). Synaptic pruning by microglia is required to promote the maturation of circuit connectivity during brain development (By similarity). Acts as an important regulator of the gut microbiota by controlling immunity to intestinal bacteria and fungi (By similarity). Expressed in lamina propria dendritic cells in the small intestine, which form transepithelial dendrites capable of taking up bacteria in order to provide defense against pathogenic bacteria (By similarity). Required to initiate innate and adaptive immune responses against dissemination of commensal fungi (mycobiota) component of the gut : expressed in mononuclear phagocytes (MNPs) and acts by promoting induction of antifungal IgG antibodies response to confer protection against disseminated C.albicans or C.auris infection (PubMed : 29326275). Also acts as a receptor for C-C motif chemokine CCL26, inducing cell chemotaxis (PubMed : 20974991).. Isoform 1. (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein.. Isoform 2. (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein (PubMed : 14607932). May have more potent HIV-1 coreceptothr activity than isoform 1 (PubMed : 14607932).. Isoform 3. (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein (PubMed : 14607932). May have more potent HIV-1 coreceptor activity than isoform 1 (PubMed : 14607932).
See full target information CX3CR1

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 25: PubMed39457094

2024

Dinochromosome Heterotermini with Telosomal Anchorages.

Applications

Unspecified application

Species

Unspecified reactive species

Alvin Chun Man Kwok,Kosmo Ting Hin Yan,Shaoping Wen,Shiyong Sun,Chongping Li,Joseph Tin Yum Wong

JCI insight 8: PubMed37345655

2023

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.

Applications

Unspecified application

Species

Unspecified reactive species

Raanan Greenman,Michal Segal-Salto,Neta Barashi,Ophir Hay,Avi Katav,Omer Levi,Ilan Vaknin,Revital Aricha,Sarit Aharoni,Tom Snir,Inbal Mishalian,Devorah Olam,Johnny Amer,Ahmad Salhab,Rifaat Safadi,Yaakov Maor,Palak Trivedi,Christopher J Weston,Francesca Saffioti,Andrew Hall,Massimo Pinzani,Douglas Thorburn,Amnon Peled,Adi Mor

BMJ open diabetes research & care 9: PubMed33568358

2021

Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice.

Applications

Unspecified application

Species

Unspecified reactive species

Namiko Kawamura,Goro Katsuura,Nobuko Yamada-Goto,Ela Novianti,Akio Inui,Akihiro Asakawa

Frontiers in immunology 11:601639 PubMed33552057

2021

Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Ahmed M Abu El-Asrar,Mohd Imtiaz Nawaz,Ajmal Ahmad,Alexandra De Zutter,Mohammad Mairaj Siddiquei,Marfa Blanter,Eef Allegaert,Priscilla W Gikandi,Gert De Hertogh,Jo Van Damme,Ghislain Opdenakker,Sofie Struyf

IBRO reports 9:233-240 PubMed32995659

2020

Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice.

Applications

Unspecified application

Species

Unspecified reactive species

Namiko Kawamura,Goro Katsuura,Nobuko Yamada-Goto,Ela Novianti,Akio Inui,Akihiro Asakawa

Journal of immunology research 2020:2932696 PubMed32884948

2020

Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Piotr Wojdasiewicz,Łukasz A Poniatowski,Andrzej Kotela,Marta Skoda,Michał Pyzlak,Aleksandra Stangret,Ireneusz Kotela,Dariusz Szukiewicz

The American journal of pathology 185:927-42 PubMed25794704

2015

Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Alec Falkenham,Roberto de Antueno,Nicole Rosin,Devin Betsch,Timothy D G Lee,Roy Duncan,Jean-Francois Légaré
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com